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Abstract
Background
For more accurate estimation of the global burden of pregnancy associated disease, clarity
is needed on definition and assessment of non-severe maternal morbidity. Our study aimed
to define maternal morbidity with clear criteria for identification at primary care level and esti-
mate the distribution of and evaluate associations between physical (infective and non-
infective) and psychological morbidities in two different low-income countries.
Methods
Cross sectional study with assessment of morbidity in early pregnancy (34%), late preg-
nancy (35%) and the postnatal period (31%) among 3459 women from two rural communi-
ties in Pakistan (1727) and Malawi (1732). Trained health care providers at primary care
level used semi-structured questionnaires documenting signs and symptoms, clinical
examination and laboratory tests which were bundled to reflect infectious, non-infectious
and psychological morbidity.
Results
One in 10 women inMalawi and 1 in 5 in Pakistan reported a previous pregnancy complication
with 1 in 10 overall reporting a previous neonatal death or stillbirth. In the index pregnancy,
50.1% of women in Malawi and 53% in Pakistan were assessed to have at least one morbidity
(infective or non-infective). Both infective (Pakistan) and non-infective morbidity (Pakistan and
Malawi) was lower in the postnatal period than during pregnancy. Multiple morbidities were
uncommon (<10%). There were marked differences in psychological morbidity: 26.9% of
women in Pakistan 2.6% inMalawi had an Edinburgh Postnatal Depression Score (EPDS) >
9. Complications during a previous pregnancy, infective morbidity (p <0.001), intra or postpar-
tum haemorrhage (p <0.02) were associated with psychological morbidity in both settings.
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Conclusions
Our findings highlight the need to strengthen the availability and quality of antenatal and
postnatal care packages. We propose to adapt and improve the framework and criteria
used in this study, ensuring a basic set of diagnostic tests is available, to ensure more
robust assessment of non-severe maternal morbidity.
Introduction
Maternal mortality is sometimes referred to as ‘the tip of the iceberg’, sitting above a poorly
documented and understood mass of morbidity. Whilst the causes of maternal mortality and
morbidity may not be simply connected, it is recognised that many women suffer both long
and short-term consequences of pregnancy delivery and the postpartum period, the major bur-
den of which affects women living in developing countries [1–3].
It has been suggested that for every woman who dies, 20 or 30 suffer morbidity that is
related to pregnancy and childbirth [4,5]. Annually, up to 20 million women worldwide are
estimated to suffer morbidity related to pregnancy and childbirth [6].
Reproductive morbidity has been defined as ‘any morbidity or dysfunction of the reproduc-
tive tract, or any morbidity which is a consequence of reproductive behaviour including preg-
nancy, abortion, childbirth, or sexual behaviour and may include those of a psychological
nature’ [7]. A proposed definition of maternal morbidity developed recently is “any condition
that is attributed to or aggravated by pregnancy and childbirth, which has a negative impact on
the woman’s wellbeing” [8].
Reproductive ill health is estimated to account for 22% of the global disease burden among
women of reproductive age (15–44 years) with pregnancy-related conditions dominating the
burden of reproductive ill health especially in developing countries [9].
Research on maternal morbidity has tended to focus on severe and life threatening acute
maternal morbidity (SAMM), also termed ‘maternal near miss’, which has now been well
defined and generally is assessed at secondary or tertiary health care levels [10–14]. In contrast,
morbidity which is not immediately life threatening, but which may be recognised at primary
level by a health care provider or perceived as morbidity by the woman herself (because it
impairs her wellbeing and is associated with adverse pregnancy outcome), is poorly docu-
mented [15–17].
A major difficulty has been the lack of a standard definition and methodology for assess-
ment of non-life threatening maternal morbidity. Previous studies describing maternal mor-
bidity each include one or several of a wide spectrum of conditions ranging from short-term
major complications such as obstetric haemorrhage and eclampsia, to long-term conditions
such as obstetric fistula or anaemia in varying combinations [18–21]. In addition, much of the
information and evidence reported to date is from hospital-based small studies with reporting
and selection biases or is found in the grey literature as reports and surveys. Thus, there is cur-
rently a lack of information and understanding regarding prevalence and burden of maternal
morbidity that is not immediately life threatening and even less data on psychological morbid-
ity associated with pregnancy, particularly in rural areas of developing countries in Asia and
Africa.
Information on women’s well-being and morbidity, both physical and psychological during
and after pregnancy is important. It should inform targeted, effective antenatal and postnatal
care packages, pre-pregnancy education and inform and support implementation of policies
Non-Life Threatening Maternal Morbidity: Malawi and Pakistan
PLOS ONE | DOI:10.1371/journal.pone.0138026 September 21, 2015 2 / 17
concerned with improving maternal and newborn health. Information of this nature is also
useful to be able to assess specific needs that are not currently addressed during “routine” ante-
natal and or postnatal care. In addition, morbidity, where this can be defined, will serve as a
useful outcome measure for effectiveness of programmes.
This study, conducted in Malawi and Pakistan, had three specific purposes: 1) to arrive at a
more concise description or definition of "maternal morbidity", including physical (infective
and non-infective) as well as psychological morbidity, with clear criteria for identification of
the cases that can be applied at primary care level; 2) to systematically estimate the extent and
distribution of physical (infective and non-infective) and psychological morbidity in two differ-
ent countries on different continents; and 3) to evaluate the associations between infective,
non-infective and psychological morbidity.
Methods
This was a community based cross sectional descriptive study using a newly developed and
standardised structured questionnaire to assess morbidity during early pregnancy (first 20
weeks), late pregnancy (last 20 weeks) and in the postnatal period (up to 6 weeks) at the pri-
mary care level in rural populations in Malawi and Pakistan.
In Malawi, the survey was conducted in a rural community in the southern region—Chirad-
zulu district. Malawi is administratively divided into 28 districts within three regions. The
health system in Malawi has three levels—primary or Health Centre level, secondary or Hospi-
tal level and a tertiary level with 2 teaching Hospitals in Lilongwe and Blantyre. In Chiradzulu
district, 95–6% of women attend one of 4 rural health centres for antenatal care and are seen
there by a local nurse-midwife who also provides postnatal care at the health centre [22,23].
There is no system of home visits for care delivery and all primary level maternal and newborn
health care is provided at the health centres which are free and on average within a 5 kilometre
range of women living in this community.
In Malawi, the age of consent at the time of the study was 16 years (for marriage) and 13
years for sexual intercourse. We checked the database for age: in Malawi, 6 girls who accessed
care and were included in the study reported their age as 15 years. All other women/girls were
aged 16 and over. In Malawi, all women, regardless of age, were seen at the point they accessed
routine antenatal or postnatal care at one of the participating clinics. All women were given a
full explanation regarding the purpose of the study in the local language and provided written
consent. For minors, accompanied by a parent or guardian, signed consent was provided (sig-
nature or thumb-print) using a consent form in the local language in the presence of the guard-
ian or parent. All consultations were undertaken by trained healthcare providers and no
additional risks were identified.
In Pakistan, the survey was carried out in Rawalpindi District situated in the north-east of
Pakistan. Pakistan is administratively divided—in descending order of size—into provinces,
division, districts, sub-districts (Tehsils), and union councils. Each union council oversees
about 10–15 villages and a population of approximately 10,000–15,000 and has a Basic Health
Unit (BHU) which has a work force consisting of a primary care physician, a Lady Health Visi-
tor (LHV), a vaccinator, mid-wives and Lady Health Workers (LHWs). LHWs are members of
the local community who have completed secondary school and are trained to provide mainly
preventive mother and child health care and education. Each LHW is responsible for a popula-
tion of 1500 people in her catchment area. In Pakistan, up to 73% of women receive antenatal
care at least once from a skilled provider [23].
In Pakistan, all married women aged 15 to 49 years, resident in the 5 Union Councils in Teh-
sil Gujar Khan who were pregnant or had given birth in the 6 weeks prior to commencement of
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the study were identified through a household survey and were invited to participate in the
study. 1750 women were approached and 13 women did not participate (5 refused and 8 were
not in the home when the LHW called).
In Pakistan, women are legally allowed to marry at 18. Seven minors were included in the
study—six reported their age as 17 years and one as 16 years. In Pakistan, all women were
interviewed in their home setting, verbal permission was obtained from the head of the house-
hold (including the parents of girls aged under 18 years) and all women regardless of age. In
addition, signed consent (signature or thumb-print) was obtained using a consent form in the
local language.
All questionnaires and assessments were conducted by nurse-midwives (Malawi) or Lady
Health Workers (Pakistan) who had been trained to use the questionnaire.
The structured questionnaire was translated into the Urdu language in Pakistan. In Malawi,
the English version was used.
The questionnaire included information on basic demographic characteristics, previous
obstetric morbidity, and current morbidity. For current morbidity, all questions were grouped
to reflect infective morbidity, non-infective morbidity and psychological morbidity.
For infective morbidity, women were asked about signs and symptoms of infections includ-
ing malaria, urinary tract infections, syphilis or other Sexually Transmitted Infections (STI),
tuberculosis and whether they were on any medication. Women in Malawi were also asked
about their HIV status. Women seen during the postnatal period were assessed for postnatal
infections such as perineal infection, mastitis, or breast abscess. To quantify the prevalence of
non-infective morbidity, women were asked about signs and symptoms of haemorrhage, pre-
eclampsia, anaemia, and other medical conditions such as nausea, vomiting, epilepsy, and
asthma. In addition, women were asked about incontinence of urine or faeces after delivery.
In addition to a standard obstetric assessment and clinical examination, simple laboratory
and clinical examinations available at the point of contact were:
Malawi
Blood Pressure, temperature, urinalysis using a simple dipstix, haemoglobin using a battery-
operated HemoCue
1
, a VDRL test for syphilis, HIV test and ultrasound assessment of gesta-
tional age (bi-parietal diameter).
Pakistan
Examination of conjunctiva for anaemia and gestational age estimated from last menstrual
period (LMP). LHWs see women when they become pregnant or relatively early in pregnancy
and LMPs are recorded at that time. LHW are not able to measure blood pressure or take
blood for haemoglobin measurement nor do they have any dipsticks to test urine. LHW can
refer women to the nearest BHU to have these examinations.
The Edinburgh Postnatal Depression Scale (EPDS) was embedded in the questionnaire to
identify psychological morbidity. The EPDS is a tool developed for screening postpartum and
pregnant women in outpatient, home visiting settings, or at the 6–8 week postpartum examina-
tion [24]. This tool has been previously used and validated in the developing country setting
[25].
In both settings, the questionnaires were first piloted among both antenatal and postnatal
women. Women found the questions easy to answer and non-threatening. Minor adjustments
in language were made. LHWs and nurse-midwives found the questions and assessments easy
to carry out as these were on the whole similar to those used during routine antenatal or post-
natal care in both settings.
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In Pakistan, the majority of the women were interviewed by the LHW at their home (89%)
and the rest at a Basic Health Unit (7%) or Health House (4%). In Malawi, all women were
seen at one of four separate Health Centres by a nurse-midwife.
Sample size calculation and analysis
In each country, for each phase of pregnancy, information was collected for a minimum of 500
women. This sample size had 80% power and a 95% confidence level to detect the prevalence
of morbidity at less than 5%.
Data collected was double entered into a Microsoft Access database, with password protection.
Data was identifiable by study number only. SPSS 22 was used to analyse the data. Simple descrip-
tive statistics were calculated to estimate the incidence of specific morbidities in this population.
The proportion of women with each sign and symptom of morbidity was calculated for
each stage of pregnancy. Signs and Symptoms were grouped to reflect specific disease condi-
tions and categorised to reflect either infective or non-infective morbidity. We calculated the
proportion of women who had only one, two, three or more infective or non-infective morbidi-
ties, and further analysed this by stage of pregnancy.
Significance testing was done with Pearson’s Chi Square, with p<0.05 set as statistically
significant.
To analyse psychological morbidity, EPDS responses were scored 0, 1, 2, or 3 according to
increased severity of the symptom. The total score was determined by adding together the scores
for each of the 10 items. Validation studies have utilized various threshold scores in determining
which women were positive and in need of referral. Cut-off scores range from 9 to 13 points [26].
For this study, we used a cut-off point of 9 to define psychological morbidity. The scale was eval-
uated for internal consistency and reliability using the Cronbach’s reliability alpha coefficient.
Morbidity was classified as infective (including malaria, HIV, tuberculosis, sexually transmit-
ted infections, sepsis) or non-infective (including haemorrhage, anaemia, pre-eclampsia, inconti-
nence, nausea and vomiting). To evaluate the relationship between psychological morbidity and
infective morbidity, non-infective morbidity, previous pregnancy history of complications and
poor outcomes, and descriptive factors such as age and parity, we conducted bivariate analyses
using logistic regression. Odds ratios with accompanying 95% confidence intervals were calcu-
lated. We used multivariate logistic regression modelling to identify all factors that were indepen-
dently and significantly associated with psychological morbidity, and to calculate their adjusted
odds ratio with 95% Confidence Intervals (CI). All variables that were statistically significant in
the bivariate analyses were included in the multivariate analysis, including descriptive variables,
previous pregnancy morbidity and outcome, infective and non-infective morbidities. Separate
multivariate models were created for each country. In creating the best logistic regression model,
the Forwards Conditional methods were used, with variables remaining in the model only if p-
values were less than 0.05 even with the addition of other variables. Models were evaluated using
the -2 log likelihood ratio statistic and the Hosmer-Lemeshow goodness of fit test.
In Malawi, the study was approved by the College of Medicine Research and Ethics Com-
mittee (COMREC). (S1 Ethical Approval) In Pakistan, ethical approval was given by the insti-
tutional review board of the Human Development Research Foundation (IRB-HDRF). (S2
Ethical Approval)
Results
Study population
In Malawi, a total of 1732 questionnaires were completed, 34.3% in early pregnancy, 34.9% in
late pregnancy and 30.8% at postnatal visit. In Pakistan, a total of 1727 women were
Non-Life Threatening Maternal Morbidity: Malawi and Pakistan
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interviewed, 33.8% in early pregnancy, 35.2% in late pregnancy and 31.0% at postnatal visit.
General characteristics of the study population are given in Table 1.
Similar to gravidity, median parity of the population was 2.0 in both settings with a maxi-
mum of 9 in Malawi and 12 in Pakistan. Mean (sd) height was 159.2 (7.0) cm in Malawi and
156.0 (13.4) cm in Pakistan. Weight was also similar; women in Malawi weighed on average
(sd) 54.7 (7.9) kg in early pregnancy compared to 54.5 (10.1) kg in Pakistan and postnatal
weight was recorded to be 55.9 (8.3) kg in Malawi and 57.6 (9.7) kg in Pakistan.
Previous pregnancy morbidity and outcome
Overall, 10.4% of women in Malawi and 22.4% of women in Pakistan reported having had a
complication during an earlier pregnancy. (Table 2) In both countries, the percentage of
women reporting a previous complication increased with parity. The percentage of women
who had been admitted to a health facility for complications in a previous pregnancy was
much higher in Pakistan (13.8%) than in Malawi (2.7%) as was the proportion who had a pre-
vious CS (21.1% vs. 5.4%) A previous miscarriage or abortion was reported by more women in
Pakistan where women register as being pregnant early compared to Malawi where women
register a pregnancy much later (20.3% vs. 7.0%). Overall, 1 in 10 women in Malawi (9.5%)
and Pakistan (11.4%) reported a previous neonatal death or stillbirth.
Current Pregnancy Morbidity
a. Infective Morbidity. Infective Morbidity is categorised and presented in Table 3.
Between 6.8% and 10.3% of women in Malawi and Pakistan respectively reported a history
of fever and feeling unwell in the month before they were seen, with more women reporting
this in the antenatal compared to postnatal period. In Malawi, all women had their temperature
checked and 0.8% had a fever (defined as>37.5° Celsius) at the time of visit. Using the criteria
defined in this study we identified a possible infective cause of reported fever in the last month
in all but 2.4% of women in Malawi and 3.1% of women in Pakistan.
Malaria was more common in Malawi than in Pakistan throughout pregnancy—with 8.1%
of women in Malawi having been treated for malaria although only a maximum of 1.0% had
been tested and had a positive malaria slide at time of visit. In Malawi, all pregnant women
receive malarial prophylaxis as part of routine antenatal care. In Pakistan, no blood tests were
conducted but 2.7% of women had received treatment for malaria and malaria prophylaxis is
not part of routine antenatal care.
The percentage of women who had signs and symptoms of a sexually transmitted infection
(using the syndromic approach) in Pakistan was much higher than in Malawi– 14.9% vs.
7.8%). This was at least in part attributable to the larger number of women reporting both vagi-
nal discharge and lower abdominal pain in Pakistan (14.2% vs. 1.2% in Malawi).
The incidence of tuberculosis or suspected tuberculosis was estimated to be 10.0% in Paki-
stan. In Malawi and Pakistan assessment or screening for tuberculosis (TBC) (other than ask-
ing about cough and medication) is not routinely done during antenatal care (ANC) or
postnatal care (PNC). Testing for HIV is not carried out in the routine ANC and PNC setting
in Pakistan, while this is done in Malawi. We calculated the proportion of women with at least
two of six conditions commonly associated with a HIV positive status: recurrent fevers, oral
thrush, chronic diarrhoea, herpes zoster, chronic cough or weight loss. In Pakistan, just over
6.3% of all women reported at least 2 of these signs and symptoms. None of these women were
on TBC treatment or had been test for HIV. In Malawi, HIV positive status was recorded by
15.4% of women, and an additional 0.6% of women who were not already known to be HIV
positive reported at least two out of these six conditions associated with positive HIV status. In
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total, 38 women had at least two of these symptoms and of these 26 were known to be HIV
positive.
Overall, 1 in 3 women reported at least one type of infective morbidity (32.6% in Malawi
and 31.6% in Pakistan). Infective morbidity was evenly spread across the time period of preg-
nancy in Malawi, with about one third of the women having at least one infection throughout
pregnancy and postnatal periods; 31.8% reported at least one infective morbidity in early
Table 1. Characteristics of study population.
Characteristics Number of women for which
information available*
Early antenatal
period*
Late antenatal
period*
Postnatal
period*
Total*
Number of respondents (%
of total)
Malawi (n 1732) 592 (34.3) 605 (34.9) 535 (30.8) 1732
Pakistan (n 1727) 584 (33.8) 608 (35.2) 535 (31.0) 1727
Age (mean, sd, years) Malawi (n 1732) 24.7 (5.8) 24.4 (5.7) 24.3 (5.1) 24.5 (5.6)
Pakistan (n 1726) 26.9 (5.2) 27.2(5.3) 27.9(5.1) 27.3 (5.2)
Gravidity (median, min, max) Malawi (n 1730) 3 (1–8) 2.5 (1–10) 2.0 (1–8) 3.0 (1–
10)
Pakistan (n 1724) 2.0 (1–11) 3.0 (1–11) 3.0 (1–12) 3 (1–12)
BMI (mean, sd) Malawi (n 1163) 21.8 +/- 3.2 22.9 +/- 3.3 22.8 +/- 3.1 22.5 +/-
3.3
Pakistan (n 426) 22.7 +/- 5.2 24.1 +/- 4.6 25.0 +/- 6.0 24.0 +/-
5.3
Gestational age at visit** Malawi (n 1068) 25.3 (4.8) weeks 32.8 (3.1) weeks 11.8 (6.3) days NA
Pakistan (n 1162) 15.9 (4.5) weeks 32.3 (4.2) weeks 13.4 (12.5) days NA
* (number/ total reporting)
** in weeks or number of days post-delivery for postnatal women (mean, sd)
doi:10.1371/journal.pone.0138026.t001
Table 2. Number and proportion of womenwho reportedmorbidity during previous pregnancy, by parity status.
% of women reporting morbidity Country 1* 2* 3* 4* > = 5* %*
Number of women Malawi 418 382 256 182 171 1409
Pakistan 438 351 243 155 197 1454
Previous Caesarean Section Malawi 6.7% (28/ 418) 7.3% (28/382) 3.1% (8/256) 1.6% (3/182) 5.3% (9/171) 5.4% (76/1409)
Pakistan 25.3% (66/
261)
25.1% (51/
203)
17.2% (23/
134)
10.6% (10/94) 18.0% (23/
128)
21.1% (173/820)
Previous neonatal death Malawi 2.9% (12/418) 4.5% (17/382) 7.4% (19/256) 9.3% (17/182) 9.4% (16/171) 5.7% (81/1409)
Pakistan 2.1% (9/420) 5.5% (19/346) 8.8% (21/240) 8.4% (13/154) 15.8% (30/
190)
6.8% (92/1350)
Previous stillbirth Malawi 1.7% (7/418) 3.1% (12/382) 3.1% (8/256) 5.5% (10/182) 9.9% (17/171) 3.8% (54/1409)
Pakistan 2.4% (10/ 420) 3.5% (12/347) 2.5% (6/240) 7.1% (11/154) 12.0% (23/
191)
4.6% (62/1352))
Previous abortion/Miscarriage Malawi 6.2% (26/418) 6.5% (25/382) 8.2% (21/256) 6.6% (12/182) 8.8% (15/171) 7.0% (99/1409)
Pakistan 13.5% (59/
438)
16.0% (56/
351)
23.5% (57/
243)
29.7% (46/
155)
32.0% (63/
196)
20.3% (281/
1383)
Complication in previous
pregnancy
Malawi 5.5% (23/418) 9.9% (38/382) 9.8% (25/256) 17.0% (31/
182)
15.2% (26/
171)
10.4% (143/
1409)
Pakistan 22.8% (97/
425)
19.9% (70/
351)
20.2% (49/
243)
23.9% (37/
155)
27.2% (53/
195)
22.4% (306/
1369)
* (number/ total reporting)
doi:10.1371/journal.pone.0138026.t002
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pregnancy, 34.8% in late pregnancy and 31.2% in the postnatal period. In Pakistan, these per-
centages were significantly different between pregnancy and postnatal periods: 34.6%, 33.4%
and 26.2%, p = 0.005. The majority of women had just one identified infective morbidity, with
less than 10% reporting multiple morbidities. (Table 4) In Malawi, further analyses revealed no
difference between stage of pregnancy and burden of infective morbidity. However, in Paki-
stan, significant differences were noted across stage of pregnancy among women who report
only one infective morbidity with less morbidity reported in the postnatal compared to the
Table 3. Signs and Symptoms of Infective Morbidity.
Signs and symptoms Early Pregnancy* Late Pregnancy* Postnatal* Total*
Malaria positive slide or treated for malaria Malawi 8.8% (52/592) 8.8% (53/ 602) 6.7% (36/534) 8.2% (141/1728)
Pakistan 3.8% (22/584) 2.3% (14/607) 2.1% (11/530) 2.7% (47/1721)
Fever of unknown origin1 Malawi 2.7% (16/592) 3.5% (21/604) 0.9% (5/535) 2.4% (39/1731)
Pakistan 3.6% (21/584) 3.2% (20/608) 2.2% (12/535) 3.1% (53/1727)
Mastitis or breast abscess Malawi 0.7% (4/535) 0.7% (4/535)
Pakistan 3.0% (16/ 528) 3.0% (16/528)
Signs and symptoms of a Urinary Tract Infection2 Malawi 4.7% (28/590) 6.2% (37/600) 5.2% (28/535) 5.4% (93/1725)
Pakistan 8.8% (51/584) 9.2% (54/ 607) 6.8% (36/530) 8.2% (141/1721)
Signs and symptoms of a Sexually Transmitted Infection3 Malawi 8.0% (47/590) 8.0% (48/601) 7.5% (40/533) 7.8% (135/1724)
Pakistan 16.4% (96/584) 15.8% (96/607) 12.1% (64/530) 14.9% (256/1721)
HIV positive or two or more HIV associated conditions4 Malawi 15.6% (92/591) 16.1% (97/602) 16.5% (88/534) 16.0% (277/1727)
Pakistan 6.7% (39/584) 5.3% (32/607) 7.0% (37/530) 6.3% (108/1721)
Tuberculosis or suspected tuberculosis5 Malawi 0.5% (3/590) 0.6% (4/602) 1.1% (6/535) 0.8% (13/1727)
Pakistan 12.0% (70/584) 10.5% (64/607) 7.2% (38/530) 10.0% (172/1721)
Hepatitis Malawi 0 0 0 0
Pakistan 1.4% (8/580) 2.1% (13/ 607) 1.1% (6/530) 1.6% (27/1717)
1 Women reporting fever and/or chills in the last four weeks for whom it is not possible to deﬁne any particular infective morbidity using study criteria.
2 Dysurea and frequency
3 Vaginal or labial ulcer or inguinal bubo OR abnormal discharge and lower abdominal pain OR VDRL positive or had benzyl penicillin in this pregnancy or
received treatment for STI.
4 Any two or more conditions associated with HIV positive status, or HIV positive.
5 Suspected tuberculosis associated with HIV positive status, or HIV positive.
* % (number/number assessed)
doi:10.1371/journal.pone.0138026.t003
Table 4. Burden of infectivemorbidity among pregnant and postnatal women in Malawi and Pakistan.
Percentage of women with infective morbidities Early Pregnancy* Late Pregnancy* Postnatal* Total*
One infective morbidity Malawi 25.2% (149/592) 28.0% (169/604) 24.5% (131/535) 25.9% (449/1731)
Pakistan1 21.9% (128/584) 24.1% (146/607) 16.8% (89/530) 21.1% (363/1721)
Two infective morbidities Malawi 5.4% (32/592) 5.3% (32/604) 5.4% (29/535) 5.4% (93/1731)
Pakistan2 8.4% (49/584) 5.6% (34/607) 5.3% (28/530) 6.4% (111/1721)
Three or more infective morbidities Malawi 1.2% (7/592) 1.5% (9/604) 1.3% (7/535) 1.3% (23/1731)
Pakistan 4.3% (25/584) 3.8% (23/607) 4.2% (22/530) 4.1% (70/1721)
1 p <0.01
2 p = 0.06; Pearson’s Chi Square
* % (number/total assessed)
doi:10.1371/journal.pone.0138026.t004
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antenatal period (p<0.01). This difference was no longer significant among women who
reported two infective morbidities (p = 0.06) or three or more morbidities (p = 0.91).
b. Non-Infective Morbidity. Bleeding was reported more commonly in Pakistan com-
pared to Malawi and in both groups post- or intra-partum bleeding was more common than
bleeding during pregnancy. Heavy bleeding at delivery was reported by similar numbers: 5.4%
in Malawi and 6.4% in Pakistan. However many more women in Pakistan had received a blood
transfusion (5.4% vs. 0.8% in Malawi). (Table 5)
Although anaemia was diagnosed using more accurate tools in Malawi (HemoCue1) than
in Pakistan (mostly conjunctiva inspection combined with symptoms of anaemia), in both set-
tings around 40% of women were found to be anaemic. Symptoms associated with anaemia
which were specifically assessed included heart palpitations, headaches, dizziness, breathless-
ness, and problems carrying out daily work because of tiredness. In Pakistan, 50% of women
reported at least two such symptoms; more in the antenatal (55.2%) compared to the postnatal
period (38.2%). In Malawi, about one in four women (23.9%) reported two or more of these
symptoms again more commonly in the antenatal (26.6%) than postnatal period (17.8%).
The occurrence of pre-eclampsia was difficult to establish in Pakistan as the LHW who sees
the woman both for antenatal and postnatal care does not measure BP or check urine using a
dipstick but has to refer for this to be done. In Pakistan, we considered a woman to have high
blood pressure if she met any of the following criteria; 1) BP measures and above 140/90 (96/
167 women), 2) reported by the LHW to be known hypertensive or, 3) on antihypertensive
medication. Proteinuria and hypertension were noted in a maximum of 1.3% women in later
pregnancy. If we included women with signs and symptoms associated with pre-eclampsia
including headache, blurred vision, and upper abdominal pain, an additional 33 cases were
identified early in pregnancy, 18 in late pregnancy and 18 in the postpartum period giving an
overall estimated occurrence of pre-eclampsia of 5.4% (74/1727).
Table 5. Signs and symptoms of non-infective morbidity.
Signs and symptoms Country Early Pregnancy* Late Pregnancy* Postnatal* Total*
Antepartum haemorrhage Malawi 0.7% (4/592) 1.5% (9/ 605) 1.7% (9/ 535) 1.3% (22/1732)
Pakistan 4.6% (27/584) 4.1% (25/608) 3.6% (19/535) 4.1% (71/1727)
Intra or Post-Partum haemorrhage1 Malawi 5.6% (30/535) 5.6% (30/535)
Pakistan 16.9% (89/528) 16.9% (89/528)
Anaemia Malawi 38.4% (206/537) 41.1% (231/562) 35.5% (22/62) 39.5% (459/1161)
Pakistan 37.8% (221/584) 39.3% (239/608) 28.0% (150/535) 35.3% (610/1727)
Pre-Eclampsia2 Malawi 0 0.2% (1/547) 0 0.2% (1/547)
Pakistan 0.5% (3/584) 1.3% (8/608) 0.6% (3/535) 0.8% (14/1727)
Incontinence of urine or faeces Malawi 0 0 0.9% (5/535) 0.9% (5/535)
Pakistan 0 0 4.7% (25/527) 4.7% (25/527)
Nausea and Vomiting Malawi 17.8% (105/590) 18.0% (108/600) 21.9% (117/535) 19.1% (330/1725)
Pakistan 30.2% (176/583) 13.7% (83/607) 12.1% (64/529) 18.8% (323/1719)
Epilepsy Malawi 0 (2/589) 0.2% (1/600) 0 0.3% (3/1189)
Pakistan 1.2% (7/583) 0.5% (3/607) 0.8% (4/529) 0.8% (14/1719)
Asthma Malawi 1.4% (8/591) 0.8% (5/602) 0.9% (5/535) 1.0% (18/1728)
Pakistan 1.9% (11/583) 1.3% (8/607) 0.9% (5/529) 1.4% (24/1719)
1 Reported heavy bleeding at delivery or in postnatal period or received a blood transfusion
2 Preeclampsia deﬁned in Malawi as (BP > 140/90 or on antihypertensive treatment) and proteinuria. In Pakistan preeclampsia deﬁned as (BP>140/90 or
on antihypertensive treatment or known to be hypertensive) and proteinuria.
* % (number/ total assessed)
doi:10.1371/journal.pone.0138026.t005
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In Malawi, no additional cases were identified using this approach. Both tests (BP and uri-
nalysis) are routinely carried out by the attending nurse-midwife providing ante and postnatal
care. In Malawi, while high blood pressure was recognised to be present in up to 4.1% of
women in late pregnancy and proteinuria present in up to 11.6% of women, both high blood
pressure and proteinuria were documented in only 0.2% of women.
Incontinence (of urine or faeces) after delivery was reported by less than 1% of women in
Malawi and around 5% in Pakistan.
One in five women reported nausea and vomiting in both settings and this was more com-
mon in early pregnancy especially in Pakistan where women are seen very early in pregnancy
by the LHW.
Including nausea and vomiting, between 40% and 50% of women in Malawi and Pakistan
respectively reported at least one non-infective morbidity with the majority identified to have
one morbidity only. When nausea and vomiting are excluded, just less than one in three
women (30.1%) in Malawi reported at least one non-infective morbidity: 38.4% in early preg-
nancy, 39.5% in late pregnancy and 11.6% in the postnatal period (p<0.01). In Pakistan this
decreased to a little more than 40% of the women who reported at least one non-infective mor-
bidity: 42.8% in early pregnancy, 42.7% in late pregnancy and 44.3% in the postnatal period,
with no statistically significant difference across the three groups (p = 0.82). The majority of
women reported only one non-infective morbidity with less than 5% in Malawi, and less than
10% in Pakistan reporting multiple non-infective morbidity. In Malawi, significant differences
were noted across pregnancy stage among women reporting only one non-infective morbidity,
with morbidity lowest in the postnatal period (p<0.001); no statistically significant differences
were noted for those reporting two or more non-infective morbidities. In contrast, differences
across pregnancy stage were not significant in Pakistan among women reporting only one
non-infective morbidity, but these differences were noted for women with two (p = 0.02) or
three or more non-infective morbidities (p = 0.04). (Table 6)
c. Psychological Morbidity. The EPDS performed well in both countries, with Cronbach’s
reliability alpha coefficient of 0.80 in Pakistan and 0.71 in Malawi. Women in Pakistan gener-
ally reported higher severity of psychological morbidity compared to women in Malawi. In
Malawi, nearly two thirds of the women did not report any psychological morbidity (EPDS
score 0) and the mean (sd) EPDS score was 3.5 (2.7) among those who scored positive for at
least one question. In Pakistan, only 20% had an EDPDS score of 0 with a mean (sd) of 7.2
(5.1) among those who scored positive for at least one section. (Fig 1).
Using a cut-off EPDS score of 9 or above, 26.9% of women in Pakistan (458/1705) and 2.6%
in Malawi (45/1728) reported psychological morbidity.
Table 6. Burden of non-infective morbidity among pregnant and postnatal women in Malawi and Pakistan.
Percentage of women with non-infective morbidities Country Early Pregnancy* Late Pregnancy* Postnatal* Total*
One non-infective morbidity Malawia 35.5% (210/592) 38.2% (231/605) 10.8% (58/535) 28.8% (499/1732)
Pakistan 34.1% (199/584) 36.7% (223/608) 32.1% (172/535) 34.4% (594/1727)
Two non-infective morbidities Malawi 1.7% (10/592) 1.3% (8/605) 0.6% (3/535) 1.2%
Pakistanb 7.4% (43/584) 4.8% (29/608) 8.8% (47/535) 6.9% (119/1727)
Three or more non- infective morbidities Malawi 0 0 0.2% (1/535) 0.2% (1/535)
Pakistan* 1.4% (8/584) 1.2% (7/608) 3.0% (16/535) 1.8% (31/1727)
* % (number/total assessed)
a p<0.001
b p<0.05; approaches signiﬁcance
doi:10.1371/journal.pone.0138026.t006
Non-Life Threatening Maternal Morbidity: Malawi and Pakistan
PLOS ONE | DOI:10.1371/journal.pone.0138026 September 21, 2015 10 / 17
In Malawi, the proportion of women with psychological morbidity (EPDS score> 9)
increased significantly across the stages of pregnancy (1.2%, 3.2%, 3.6%, p = 0.02). In Pakistan,
however, this trend was not significant (25.8%, 26.9%, 28.1%; p = 0.69), with around one in
four women in Pakistan reporting psychological morbidity throughout pregnancy.
d. Association between Infective, non-Infective, and Psychological Morbidity. Overall,
53% of women in Pakistan and 50.1% in Malawi reported at least one morbidity (infective or
non-infective). In Malawi, 11.4% (197/1732) and Pakistan 21.5% (372/1727) of women were
identified to have both infective and non-infective morbidity.
In both countries, significant increases in odds of psychological morbidity were noted for
women who had complications during a previous pregnancy while previous experience of a
stillbirth or neonatal death (alone) was not associated with increased odds of psychological
morbidity. (Table 7)
For infective morbidity having signs and symptoms of a UTI, STI or being HIV positive or
having signs and symptoms associated with HIV positivity were all independently significantly
associated with psychological morbidity (Table 7) with an overall doubling of the odds of
reporting psychological morbidity in Pakistan and trebling in Malawi with any identified mor-
bidity. (Pakistan OR: 1.91; 95%CI 1.69, 2.17; p<0.0001; Malawi OR: 2.89; 95% CI 2.17, 3.83; p
<0.0001)
Results of non-infective morbidity in Pakistan show significant increases in odds for women
with intra and postpartum haemorrhage but not for antepartum haemorrhage. In Malawi,
Fig 1. Distribution of EPDS scores for rural women in Malawi and Pakistan.
doi:10.1371/journal.pone.0138026.g001
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results show significantly increased odds for women reporting any type of haemorrhage. Pre-
eclampsia and anaemia were significantly associated with increased psychological morbidity in
Pakistan but not in Malawi. And while increasing burden of non-infective morbidity more
than doubles the odds of high psychological morbidity among pregnant women in Pakistan
(OR: 2.24; 95% CI 1.93, 2.61; p<0.0001), this was not significant in Malawi (OR: 1.39; 95%CI
0.80, 2.42; p = 0.24)).
In Malawi, significant increases in odds of psychological morbidity were found with increas-
ing age (OR: 1.11, 95% CI 1.06, 1.16; p<0.0001) and parity (OR: 1.43; 95% CI 1.22, 1.67; p
<0.0001). In Pakistan, no differences were noted by age (p = 0.56), and while a slight increase
in odds were noted for parity, this only approached statistical significance (p = 0.07).
Multivariate logistic regression show that for Malawi, after controlling for parity and preg-
nancy stage, antepartum bleeding increased the odds of psychological morbidity 5-fold (OR:
5.01; 95% CI 1.60, 15.70; p = 0.006), while increasing burden of infective morbidity (i.e. for
each additional infective morbidity) showed slightly more than 2.5 fold increase in the odds of
Table 7. Association between psychological morbidity, infective morbidity, non-infective morbidity and previous pregnancy outcome.
Previous pregnancy outcome Country OR 95% CI p-value
Complication in previous pregnancy Malawi 2.87 1.35–6.08 0.006
Pakistan 2.0 1.55–2.59 <0.0001
Complication in previous postnatal period Malawi 2.92 1.12–7.64 0.03
Pakistan 1.56 1.23–1.98 <0.0001
Previous stillbirth or neonatal death Malawi 1.52 0.59–3.92 0.39
Pakistan 1.32 0.98–1.79 0.07
Infective Morbidity
Malaria Malawi 2.13 0.93–4.86 0.07
Pakistan 2.57 1.43–4.63 0.002
UTI signs and symptoms Malawi 8.14 4.11–16.11 <0.0001
Pakistan 2.93 2.06–4.17 <0.0001
STI signs and symptoms Malawi 3.09 1.46–6.56 0.003
Pakistan 3.2 2.44–4.23 <0.0001
HIV Positive1 Malawi 5.58 2.96–9.80 <0.0001
Pakistan 3.63 2.43–5.43 <0.0001
Non-infective Morbidity
Antepartum Haemorrhage Malawi 7.67 2.81–20.91 <0.0001
Pakistan 1.44 0.81–2.39 0.16
Intra or Postpartum Haemorrhage Malawi 4.38 1.28–15.01 0.02
Pakistan 1.60 1.08–2.66 0.02
Anaemia Malawi 0.79 0.39–1.60 0.51
Pakistan 3.15 2.52–3.93 <0.0001
Pre-Eclampsia Malawi 0 - 1.0
Pakistan 3.13 2.05–4.77 <0.0001
Incontinence of Urine or Faeces Malawi 0.0 — 1.0
Pakistan 2.17 0.98–4.81 0.06
Nausea and Vomiting Malawi 1.57 0.80–3.08 0.19
Pakistan 1.39 1.07–1.81 0.14
1 In Malawi, HIV positive individuals are those who tested positive or had 2 or more signs and symptoms of HIV, while in Pakistan, HIV positive individuals
are those with 2 or more signs and symptoms of HIV
doi:10.1371/journal.pone.0138026.t007
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having psychological morbidity (OR: 2.58; 95% CI 1.92, 3.47; p = 0.000). No other factors were
significant.
For Pakistan, results show a 56% increase in odds of psychological morbidity due to increas-
ing burden of infective morbidity (OR: 1.56; 95% CI 1.36, 1.79; p = 0.000), and a 78% increased
odds due to increasing burden of non-infective morbidity (OR: 1.78; 95% CI 1.51, 2.11;
p = 0.000), when controlling for the effect of complication during a previous pregnancy. No
other factors were important.
Discussion
In calculating the overall burden of ill-health associated with pregnancy and childbirth, it is
important to define and estimate the incidence of pregnancy associated morbidity. Assessment
of the extent of maternal morbidity is also an important step to ensure appropriate health care
intervention packages are in place. For more accurate estimation of the global burden of mater-
nal morbidity, clarity is needed on definition, assessment must be at population level and self-
reported morbidity may need to be validated [1,2,17].
For the first time we have applied a standardised model and criteria for assessment of non-
life threatening maternal morbidity which can be applied in a primary care setting as part of
existing ante and postnatal care packages, and which addresses a major component along the
continuum of maternal health. Using this method, more than half the women in Pakistan and
Malawi were identified to have morbidity including 1 in 3 with infective and a similar propor-
tion with non-infective morbidity. Very few women (less than 10%) were identified to have
multiple morbidities in either category. By bundling reported symptoms and signs together
with basic clinical examinations and laboratory tests this study confirms that women in low
and middle income countries are likely to have a high burden of morbidity during pregnancy
and the postpartum period. It may not be possible to confirm or refute specific conditions or
disease in many cases given the absence of more precise diagnostic testing. However, the preva-
lence of anaemia in the women in our study in Malawi (40%) is similar to that reported in the
Demographic Health Survey in Malawi in 2010 (38%) [27].
The earliest reported estimate of maternal morbidity is from a prospective study among 280
women in rural India who were followed for 5 years and visited monthly. This study reported
pregnancy related morbidity in 30% of women [28]. A larger cross sectional community based
study from India among women aged less than 35 years with at least one child under 5 years
old found that 41% of women had experienced morbidity during the last pregnancy [29]. Post-
partum morbidity was assessed by trained village workers in India in the first 28 days after
delivery and estimated to occur in up to 42.9% of women [30].
A number of other community based surveys have remained unpublished: in 1995, a cross
sectional survey of 7325 households across one Governate in Egypt reported the burden of
maternal morbidity based on women’s self-reported symptoms [31]. Overall, 82.8% of women
reported morbidity in the antenatal period, 20.4% intrapartum, and 19.1% postpartum. The
majority of women perceived these as serious health problems (80.3%). A similar study from
Uganda in 1993 among 1261 women in 12 districts reported that 10.6% of women reported
signs and symptoms of pre-eclampsia and eclampsia. Fever (44.9%), excessive headaches
(26.9%), severe vomiting (19.6%), anaemia (19.0%) were the most frequently reported preg-
nancy related morbidities among women in Uganda [32]. Other authors have suggested an
‘enormous but unaddressed problem shrouded in a culture of silence and endurance’ [3,7,33].
The limitations of self-reporting are well recognised but it could be argued that these are signs
and symptoms which women themselves consider as significantly contributing to ‘non-health’
or associated with adverse pregnancy outcome.
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In our study, we have supplemented women’s reported signs and symptoms with simple
clinical examination and diagnostic tests that are usually available in the antenatal and postna-
tal care settings in low and middle income settings.
The methodology we propose for identification of morbidity was found to be easy to apply
and very acceptable in the primary care setting in both Malawi and Pakistan but the robustness
with which an exact diagnosis of morbidity could be made relied on available clinical and labo-
ratory examinations. These are currently still very limited in most primary care settings in
developing countries even though this is where the majority of women receive ante and postna-
tal care and despite clear guidelines regarding content of antenatal care packages [34,35]. Sim-
ple diagnostic technology such as a battery operated HemoCue1 or Haemoglobin Colour Scale
to measure haemoglobin and urine dipsticks to measure proteinuria should be available in
these settings [36]. The competence of the health care worker providing ante and postnatal
care also needs to be taken into consideration, for example, it can be argued that any health
care provider at primary care level who is expected to provide antenatal and postnatal care
should be able to measure blood pressure and we note that this is currently not the case in a
number of settings especially in Asia. Testing for HIV and syphilis requires minimal infrastruc-
ture and equipment and are both part of the core WHO antenatal care package. We note that
between the two settings in this study practice was different; in Pakistan care was provided in
or close to a woman’s home setting whereas in Malawi this was in a primary care health centre
setting. However this also had implications for the level of clinical examination and diagnostic
testing that was possible. Finally, where morbidity is recognised and identified it is important
that health care providers have a clear pathway for further diagnostics, treatment or referral as
needed. The findings of this study highlight the need to strengthen the ‘enabling environment’
and to improve the availability, content and quality of ante and postnatal care at primary care
level in developing country settings.
A major contribution of this study is its evaluation of psychological morbidity as part of a
comprehensive assessment of morbidity during pregnancy and the postpartum period. We
found a remarkable difference between reported psychological morbidity in Pakistan where 1
in 4 women reported signs and symptoms of psychological morbidity whereas this was
reported by less than 5% in Malawi. This may in part be due to differences in the way that data
were collected—more private home setting in Pakistan compared to the more public less inti-
mate, health centre in Malawi which could negatively affect disclosure. In addition, women in
Malawi are generally active in agricultural or other work and not confined to the home envi-
ronment as much as women in Pakistan might be. Finally, in many African settings, admitting
to problems or feelings of anxiety or worry may be associated with ‘wishing this upon oneself’
limiting the use of a tool such as the Edinburgh Postnatal Depression Scale (EPDS). Thus,
there is likely to be a variety of cultural and social practices and beliefs surrounding pregnancy
which contribute to or prevent anxiety, depressed mood, and depression as well and determine
if and how a woman can express this. A recent systematic review of perinatal mental health in
pregnancy in Africa reported prevalence rates not dissimilar to women in developed countries
but ranging between 4.3% and 17.4% during pregnancy and 3.2% to 48.0% postnatally [37]. In
Pakistan, an earlier study using a combination of assessment tools identified 36% of postnatal
women with high EPDS scores (>12) in the postnatal period [38]. The EPDS is the most widely
used screening tool for postpartum depression and has also been extensively used in the ante-
natal period. A systematic review of validation studies reported a wide variety of cut off points
and highlighted that this tool may not be equally valid across all settings [26]. A study from
Ethiopia suggested limited validity of the EPDS in rural low income sub Saharan Africa com-
pared to more urban populations [39]. It is widely recognised that there are a variety of ques-
tionnaires, including the EPDS, which examine depressive mood and are not diagnostic
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measures per se and most previous studies in Africa used a two phase approach: a question-
naire followed by clinical examination [36]. Although in this study the EPDS displayed good
internal reliability in both countries (using Cronbach’s alpha score), studies which use more
detailed interviews to diagnose depression may be required. Further research is needed to
explore the reasons for these differences in psychological well-being including more explor-
atory and qualitative research methodology.
This was a cross sectional study and we were not able to assess if reported morbidity in the
index pregnancy was associated with adverse pregnancy outcome. This would need further
prospective studies in a variety of settings using a framework and criteria for assessing morbid-
ity that is acceptable and applicable at population level. Assessments of maternal morbidity
will need to be carried out in a wide variety of settings in low and middle income countries to
capture the true burden of disease. We propose to adapt and improve the framework and crite-
ria used in this study, ensuring a basic set of diagnostic tests is available to ensure more robust
assessment of morbidity.
Maternal mortality has often been considered the primary indicator of maternal health. If
maternal morbidity can be defined and assessed this could serve as an additional indicator
which in particular will be useful to help evaluate effect of shorter term intervention pro-
grammes or those that cannot cover the large population groups needed to measure effect on
mortality. It will be useful to be able to divide the morbidity–mortality spectrum into meaning-
ful and defined clinical ranges. In the US, where maternal morbidity is classified as a public
health problem, the ‘Healthy People 2010’ includes maternal morbidity during labour and
delivery as new indicator for maternal health and there are calls to expand this further to
include ante and postnatal morbidity [40].
As clinical decision making and care improves across this spectrum, maternal outcomes can
be expected to improve [41]. By addressing both maternal morbidity and mortality, we can
aspire to prevent not only unnecessary deaths but also complications of pregnancy.
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